HOPE BIOSCIENCES STEM CELL RESEARCH FOUNDATION (EIN 843802908) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

DONNA CHANG

Phone

7133332200

Tax Period

2024-01-01 to 2024-12-31

HOPE BIOSCIENCES STEM CELL RESEARCH FOUNDATION, founded in 2019, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $3.4M in total revenue in fiscal year 2024. Revenue surged 142% from the prior year, signaling strong growth momentum. The organization ran a surplus of $2.1M, a strong 63% operating margin.

Mission

TO FUND TRANSLATIONAL RESEARCH IN REGENERATIVE MEDICINE TO DEVELOP CURES FOR ALL.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,908,093

Program Service Revenue $463,833

Investment Income $129,986

Other Revenue $-113,337

TOTAL REVENUE $3,388,575

Expense Breakdown

Grants Paid $0

Salaries & Benefits $784,710

Fundraising Expenses $52,948

Program Expenses $1,021,166

Other Expenses $483,519

TOTAL EXPENSES $1,268,229

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,388,575	$1,399,765	+1.4%
Expenses	$1,268,229	$1,038,425	+0.2%
Net Income	$2,120,346	$361,340	+4.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$7,547

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LISA YOUNG	CHAIR/DIRECTOR	1.00	Officer Director	$0	$0	$0
GINGER HITE	SECRETARY/DIRECTOR	1.00	Officer Director	$0	$0	$0
DOUG BAUER	DIRECTOR	1.00	Director	$0	$0	$0
GORDON BETHUNE	DIRECTOR	1.00	Director	$0	$0	$0
MANDY KAO	DIRECTOR	1.00	Director	$0	$0	$0
DONNA CHANG	PRESIDENT	1.00	Officer	$0	$0	$0
DANIEL CHANG	TREASURER/IT SPECIALIST	20.00	Officer	$7,540	$7	$7,547
DAVID GONZALEZ	CLINICAL AFFAIRS SPECIALIST	40.00	Highest	$108,728	$18,131	$126,859

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$3,388,575	$1,268,229	$3,926,859	$2,120,346
2023	$1,399,765	$1,038,425	$1,813,473	$361,340
2022	$356,381	$1,780,729	$364,822	$-1,424,348
2021	$895,977	$1,930,346	$1,307,055	$-1,034,369
2020	$3,560,851	$1,270,217	$2,375,850	$2,290,634

HOPE BIOSCIENCES STEM CELL RESEARCH FOUNDATION